Dr. Reddy's Laboratories Limited
RDY
Cena:
$ 13.60
+0.05 (0.37%)
Valuace
93
Růst
63
Zdraví
84
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
DR. REDDY'S ANNOUNCES THE FIRST-TO-MARKET LAUNCH OF OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP, 0.7% (OTC), THE GENERIC EQUIVALENT OF EXTRA-STRENGTH PATADAY® ONCE DAILY RELIEF, IN THE U.S.
14-01-2026
HYDERABAD, INDIA & PRINCETON, N.J.--(BUSINESS WIRE)---- $RDY #ANTIHISTAMINEEYEDROP--DR. REDDY'S LAUN...
Více zde
IMMUTEP AND DR. REDDY’S ENTERS INTO STRATEGIC COLLABORATION FOR COMMERCIALISATION OF AN INNOVATIVE ONCOLOGY DRUG, EFTILAGIMOD ALFA
08-12-2025
DR. REDDY'S RECEIVES EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALISE EFTILAGIMOD ALFA IN ALL COUNTRIES...
Více zde
AURIGENE ONCOLOGY LIMITED ANNOUNCES ENCOURAGING INITIAL DATA FROM 1ST TWO COHORTS OF PHASE 1 STUDY OF AUR112, AN ORAL SMALL MOLECULE INHIBITOR OF MALT1, IN RELAPSED/REFRACTORY LYMPHOID MALIGNANCIES
02-12-2025
BANGALORE, INDIA--(BUSINESS WIRE)-- #AURIGENEONCOLOGY--AURIGENE ONCOLOGY LIMITED ANNOUNCES ENCOURAGI...
Více zde
EXTROVIS AG AND DR. REDDY'S ANNOUNCE THE LAUNCH OF THE AUTHORIZED GENERIC OF CARAC (FLUOROURACIL CREAM), 0.5% IN THE U.S.
18-08-2025
EXTROVIS AG BAHNHOF PARK 46340, BAAR, SWITZERLAND MEDIA RELATIONS CONTACT MADHU MARUR MADHU.MARUR@EX...
Více zde
DR. REDDY'S Q1FY26 FINANCIAL RESULTS
23-07-2025
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #CONSOLIDATEDFINANCIALRESULTS--DR. REDDY'S LABORATORIES L...
Více zde
ALVOTECH AND DR. REDDY'S ENTER INTO COLLABORATION TO CO-DEVELOP BIOSIMILAR CANDIDATE TO KEYTRUDA® (PEMBROLIZUMAB)
05-06-2025
HYDERABAD, INDIA & REYKJAVIK, ICELAND--(BUSINESS WIRE)---- $RDY #ALVOTECH--ALVOTECH AND DR. REDDY'S ...
Více zde
DR. REDDY'S Q4 & FULL YEAR FY25 FINANCIAL RESULTS
09-05-2025
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED I...
Více zde
BIO-THERA AND DR. REDDY'S EXECUTE EXCLUSIVE COMMERCIALIZATION AGREEMENT FOR BAT2206, A PROPOSED STELARA® BIOSIMILAR, AND BAT2506, A PROPOSED SIMPONI® BIOSIMILAR, FOR SOUTHEAST ASIA
27-03-2025
GUANGZHOU, CHINA AND HYDERABAD, INDIA , MARCH 27, 2025 /PRNEWSWIRE/ -- BIO-THERA SOLUTIONS (688177...
Více zde
ALVOTECH AND DR. REDDY'S ANNOUNCE FDA ACCEPTANCE OF BIOLOGIC LICENSE APPLICATION FOR AVT03, A PROPOSED BIOSIMILAR TO PROLIA® AND XGEVA®
18-03-2025
HYDERABAD, INDIA & REYKJAVIK, ICELAND--(BUSINESS WIRE)---- $RDY #AVT03--ALVOTECH AND DR. REDDY'S ANN...
Více zde
DR. REDDY'S ISSUES A NATIONWIDE RECALL OF LEVETIRACETAM IN 0.75% SODIUM CHLORIDE INJECTION 1,000 MG/100 ML, IN THE U.S., DUE TO MISLABELING OF INFUSION BAG
13-03-2025
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDYS--DR. REDDY'S ISSUES A NATIONWIDE RECALL OF LEVE...
Více zde
DR. REDDY'S ENTERS INTO COLLABORATION WITH HENLIUS FOR COMMERCIALIZATION OF HLX15 (DARATUMUMAB), A BIOSIMILAR CANDIDATE TO DARZALEX® & DARZALEX FASPRO® IN THE U.S., AND EUROPE
06-02-2025
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S LABORATORIES SA TODAY ANNOUNCED THA...
Více zde
HENLIUS AND DR. REDDY'S INK LICENSING DEAL FOR HLX15 (INVESTIGATIONAL DARATUMUMAB BIOSIMILAR) EXPANSION IN EUROPE AND THE U.S.
06-02-2025
SHANGHAI , FEB. 6, 2025 /PRNEWSWIRE/ -- SHANGHAI HENLIUS BIOTECH, INC. (2696.HK) TODAY ANNOUNCED I...
Více zde
DR. REDDY'S Q3 & 9MFY25 FINANCIAL RESULTS
23-01-2025
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #9MFY25--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED IT...
Více zde
DR. REDDY'S LAUNCHES TORIPALIMAB IN INDIA, THE FIRST AND ONLY IMMUNO-ONCOLOGY DRUG APPROVED FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA
28-11-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S LABORATORIES LTD. ANNOUNCED THE LAU...
Více zde
DR. REDDY'S LABORATORIES AND SENORES PHARMACEUTICALS, INC. ANNOUNCE THE LAUNCH OF IVERMECTIN TABLETS USP, 3 MG IN US MARKET
26-11-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDYS--DR. REDDY'S LABORATORIES, INC. AND SENORES PHA...
Více zde
DR. REDDY'S Q2 & H1FY25 FINANCIAL RESULTS
05-11-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDYS--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED ...
Více zde
DR. REDDY'S NAMED BY SCIENCE MAGAZINE IN TOP 20 GLOBAL PHARMA EMPLOYERS LIST FOR THIRD CONSECUTIVE YEAR
25-10-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #AMERICANASSOCIATIONFORTHEADVANCEMENTOFSCIENCE--DR. REDDY...
Více zde
DR. REDDY'S LAUNCHES COMPREHENSIVE MENOPAUSE SUPPORT PROGRAM AND TRAINING FOR EMPLOYEES DURING MENOPAUSE AWARENESS MONTH
14-10-2024
PRINCETON, N.J.--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S LAUNCHES COMPREHENSIVE MENOPAUSE SUP...
Více zde
AURIGENE ONCOLOGY LIMITED ANNOUNCES PROMISING RESULTS OF PHASE 1 STUDY FOR INDIA'S FIRST TRIAL FOR NOVEL AUTOLOGOUS CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
08-10-2024
BENGALURU, INDIA & HYDERABAD, INDIA--(BUSINESS WIRE)-- #AURIGENEONCOLOGY--AURIGENE ONCOLOGY ANNOUNCE...
Více zde
DR. REDDY'S SIGNS VOLUNTARY LICENSING AGREEMENT WITH GILEAD SCIENCES TO MANUFACTURE AND COMMERCIALISE LENACAPAVIR IN INDIA AND OTHER COUNTRIES
02-10-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S SIGNS VOLUNTARY LICENSING AGREEMENT...
Více zde
DR. REDDY'S RECEIVES POSITIVE CHMP OPINION FROM EUROPEAN MEDICINES AGENCY FOR ITS PROPOSED RITUXIMAB BIOSIMILAR
29-07-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #CHMP--DR. REDDY'S RECEIVES POSITIVE CHMP OPINION FROM EU...
Více zde
DR. REDDY'S Q1FY25 FINANCIAL RESULTS
27-07-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED I...
Více zde
DR. REDDY'S TO ACQUIRE NICOTINELL AND RELATED PORTFOLIO IN SIGNIFICANT STEP TOWARDS BUILDING GLOBAL CONSUMER HEALTHCARE BUSINESS
26-06-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #ACQUISITION--DR. REDDY'S TO ACQUIRE NICOTINELL AND RELAT...
Více zde
AURIGENE PHARMACEUTICAL SERVICES LIMITED, A GLOBAL CRDMO, ANNOUNCES THE OPENING OF ITS BIOLOGICS FACILITY OFFERING PROCESS DEVELOPMENT AND CLINICAL SCALE MANUFACTURING CAPABILITIES
03-06-2024
HYDERABAD, INDIA--(BUSINESS WIRE)-- #AURIGENE--AURIGENE INAUGURATED ITS BIOLOGICS FACILITY SPREAD AC...
Více zde
DR. REDDY'S LABORATORIES ANNOUNCES THE APPOINTMENT OF MILAN KALAWADIA TO CEO NORTH AMERICA
28-05-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #CEO--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED THE A...
Více zde
ALVOTECH AND DR. REDDY'S ENTER INTO COLLABORATION FOR COMMERCIALIZATION OF AVT03 (DENOSUMAB), A BIOSIMILAR CANDIDATE TO PROLIA® & XGEVA® IN THE U.S., EUROPE AND UK
21-05-2024
HYDERABAD, INDIA & REYKJAVIK, ICELAND--(BUSINESS WIRE)---- $RDY #ALVOTECH--ALVOTECH AND DR. REDDY'S ...
Více zde
DR. REDDY'S Q4 & FULL YEAR FY24 FINANCIAL RESULTS
07-05-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #DRREDDY--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED I...
Více zde
DR. REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF DOXYCYCLINE CAPSULES, 40 MG* IN THE U.S.
03-05-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #CAPSULES--DR. REDDY'S LABORATORIES ANNOUNCES THE LAUNCH ...
Více zde
DR. REDDY'S LABORATORIES LAUNCHES VERSAVO® (BEVACIZUMAB) IN THE UK
19-03-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #AVASTIN--DR. REDDY'S LABORATORIES LTD., A GLOBAL PHARMAC...
Více zde
DR. REDDY'S Q3 & 9M FY24 FINANCIAL RESULTS
31-01-2024
HYDERABAD, INDIA--(BUSINESS WIRE)---- $RDY #9MFY24--DR. REDDY'S LABORATORIES LTD. TODAY ANNOUNCED IT...
Více zde
Dokumenty nejsou k dispozici
